Edwards Lifesciences

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell EW and other ETFs, options, and stocks.

About EW

Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. 

CEO
Bernard J. Zovighian
CEOBernard J. Zovighian
Employees
16,000
Employees16,000
Headquarters
Irvine, California
HeadquartersIrvine, California
Founded
1958
Founded1958
Employees
16,000
Employees16,000

EW Key Statistics

Market cap
47.21B
Market cap47.21B
Price-Earnings ratio
44.25
Price-Earnings ratio44.25
Dividend yield
Dividend yield
Average volume
4.43M
Average volume4.43M
High today
$82.17
High today$82.17
Low today
$80.08
Low today$80.08
Open price
$81.12
Open price$81.12
Volume
4.44M
Volume4.44M
52 Week high
$87.89
52 Week high$87.89
52 Week low
$65.94
52 Week low$65.94

Stock Snapshot

The current Edwards Lifesciences(EW) stock price is $81.26, with a market capitalization of 47.21B. The stock trades at a price-to-earnings (P/E) ratio of 44.25.

On 2026-04-01, Edwards Lifesciences(EW) stock moved within a range of $80.08 to $82.17. With shares now at $81.26, the stock is trading +1.5% above its intraday low and -1.1% below the session's peak.

Trading activity shows a volume of 4.44M, compared to an average daily volume of 4.43M.

Over the past 52 weeks, Edwards Lifesciences(EW) stock has traded between a high of $87.89 and a low of $65.94.

Over the past 52 weeks, Edwards Lifesciences(EW) stock has traded between a high of $87.89 and a low of $65.94.

EW News

TipRanks 10h
Edwards Lifesciences upgraded to Outperform from Peer Perform at Wolfe Research

Wolfe Research upgraded Edwards Lifesciences (EW) to Outperform from Peer Perform with a $92 price target. Checks suggest Medtronic’s (MDT) long-term Evolut TAV...

Nasdaq 2d
S&P 500 Analyst Moves: EW

The latest tally of analyst opinions from the major brokerage houses shows that among the components of the S&P 500 index, Edwards Lifesciences is now the #89 a...

S&P 500 Analyst Moves: EW
Nasdaq 2d
Edwards Lifesciences Achieves #89 Analyst Rank, Surpassing Darden Restaurants

In a study of analyst recommendations at the major brokerages, for the underlying components of the S&P 500, Edwards Lifesciences Corp (Symbol: EW) has taken ov...

Edwards Lifesciences Achieves #89 Analyst Rank, Surpassing Darden Restaurants

Analyst ratings

72%

of 32 ratings
Buy
71.9%
Hold
28.1%
Sell
0%

More EW News

TipRanks 2d
Edwards Lifesciences announces new data on EVOQUE TTVR system

Edwards Lifesciences (EW) announced new data on the EVOQUE transcatheter tricuspid valve replacement system at the American College of Cardiology Annual Scienti...

Simply Wall St 3d
Should Philips’ New AI Imaging Clearance for PASCAL Ace Reshape Edwards Lifesciences’ Structural Heart Narrative?

In recent days, analysts have been preparing for Edwards Lifesciences’ upcoming fiscal first-quarter 2026 earnings release, while Royal Philips secured FDA 510(...

Should Philips’ New AI Imaging Clearance for PASCAL Ace Reshape Edwards Lifesciences’ Structural Heart Narrative?
Simply Wall St 5d
Is Edwards Lifesciences Pricing Look Attractive After Recent Pullback?

If you are wondering whether Edwards Lifesciences at around US$79.34 is a bargain or fully priced, you are in the right place for a clear valuation checkup. Th...

Is Edwards Lifesciences Pricing Look Attractive After Recent Pullback?

People also own

Based on the portfolios of people who own EW. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.